企業プロフィール
Merrimack 株価・ニュース・カタリスト
- ティッカー:
- MACK
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for MACK.
企業概要
事業概要
Merrimack was an oncology company focused on targeted cancer medicines before its corporate restructuring and delisting history. Its legacy was tied to the challenge of turning oncology science into commercial value.
所在地とセクター分類
Headquartered in the United States and formerly listed on NASDAQ, Merrimack sat in oncology biotechnology.
ビジネスモデルの特徴
The business depended on clinical development, commercialization execution, and strategic portfolio decisions.
バイオ業界での位置付け
Merrimack belongs to the historical oncology-biotech category rather than the current public-company set.
今後のカタリスト
- Merrimack’s catalysts are zenocutuzumab royalties and any remaining oncology development or monetization update. The market will watch whether the company can keep turning a concentrated asset base into visible value.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。